| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/11/2002 | US6403561 Disorders associated with the inactivation or excessive degradation of cholecystokinin; inhibiting the enzymatic hydrolysis of cholecystokinin 1-(2(s)-aminobutyryl)-2(s)-indolinecarboxylic acid |
| 06/11/2002 | US6403555 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/11/2002 | US6403112 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 06/06/2002 | WO2002044324A2 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 06/06/2002 | WO2002043773A2 Tissue specific prodrugs |
| 06/06/2002 | WO2001079242A3 Process for preparing lipid ii and derivatives thereof |
| 06/06/2002 | WO2001074768A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/06/2002 | WO2001042225A8 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/06/2002 | US20020068747 Inhibitors of prenyl-protein transferase |
| 06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 06/06/2002 | US20020068695 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 06/05/2002 | EP1211249A1 Novel thiazine or pyrazine derivatives |
| 06/05/2002 | EP1210361A1 Stabilisation of freeze-dried cake |
| 06/05/2002 | EP1210360A1 Compounds useful to mimic peptide beta-strands |
| 06/05/2002 | EP1210355A2 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 06/05/2002 | EP1141375A4 Metallopeptide combinatorial libraries and applications |
| 06/05/2002 | EP1071442A4 Methods and compositions for peptide synthesis |
| 06/05/2002 | EP0871443B1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | US6399629 Efflux pump inhibitors |
| 06/04/2002 | US6399601 Antidiabetic agents; nervous system disorders; anticholesterol agents |
| 06/04/2002 | US6399599 Substituted 2-oxo-1,4-diazacycloalkanes |
| 06/04/2002 | US6399568 Anticancer agents |
| 06/04/2002 | US6399132 Sweetener composition |
| 06/04/2002 | US6399053 Methods of enhancing bioactivity of chemokines |
| 06/04/2002 | CA2205198C Human neutrophil elastase inhibitors |
| 06/04/2002 | CA2174097C Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042414A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 05/30/2002 | WO2002042412A2 Protease inhibitors and their pharmaceutical uses |
| 05/30/2002 | WO2002042295A2 Peptides as met-ap2 inhibitors |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2001096364A3 Peptides that stimulate cell survival and axon regeneration |
| 05/30/2002 | WO2001042282A9 Depsipeptide and congeners thereof for use as immunosuppressants |
| 05/30/2002 | WO2001037194A9 Crystallizable compositions comprising a caspase-7 |
| 05/30/2002 | WO2001016300A3 Method of identifying inhibitors of cdc25 |
| 05/30/2002 | US20020065416 Anti-inflammatory agents |
| 05/30/2002 | US20020065391 Compound for use in the treatment of arthritis, inflammatory bowel disease, nervous system and cardiovascular disorders, arteriosclerosis, restenoses, diabetes, grafted organ damage, asthma, allergies, tumor metastasis and malaria |
| 05/30/2002 | US20020065284 Dipeptide derivatives |
| 05/30/2002 | US20020065228 Inhibition of biosynthesis of a digestive enzyme of blood-ingesting pests known to feed on humans and animals; insecticides; pesticides; miticides; beetles; moths; flies; fleas; mosquitoes; lice |
| 05/30/2002 | US20020065219 Water soluble thiazolyl peptide derivatives |
| 05/30/2002 | US20020064501 Determining peptide's therapeutic effect by administering to subject prone to showing signs of diabetes; determining development of diabetes |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/29/2002 | EP1209167A1 Method of producing a biosensor protein capable of regulating a fluorescence property of the modified green fluorescent protein therein, and the biosensor protein produced by the method |
| 05/29/2002 | EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 05/29/2002 | EP1208377A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 05/29/2002 | EP1208238A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
| 05/29/2002 | EP1207897A2 Pharmaceutical compositions containing tripeptides |
| 05/29/2002 | EP1207873A1 Methods of inhibiting osteoclast activity |
| 05/29/2002 | CN1351609A Low-molecular inhibitors of complement proteases |
| 05/29/2002 | CN1351587A Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 05/28/2002 | US6395763 Antitumor, anticancer agents; immunosuppressant |
| 05/28/2002 | US6395532 Modified enzymes and their use for peptide synthesis |
| 05/28/2002 | US6395474 Peptide nucleic acids |
| 05/28/2002 | CA2054715C Process for the preparation of n-protected dialkyl(2s,3s)-3-ethylaspartates |
| 05/23/2002 | WO2002040631A2 Dipeptide seryl-histidine and related oligopeptides cleave dna, protein, and a carboxyl ester |
| 05/23/2002 | WO2002040508A2 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 05/23/2002 | WO2002040507A2 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers |
| 05/23/2002 | WO2002040040A1 Camptothecin compounds with a sulfhydryl group |
| 05/23/2002 | WO2002002596A3 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 05/23/2002 | WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 05/23/2002 | WO2001027077A3 Hydroxysulfonylalkylene-, phosphonoalkylene- or difluoro(phosphononon)methyl- substituted benzene, or benzofuran derivatives as non-peptidic cdc25 inhibitors |
| 05/23/2002 | US20020061909 Vitronectin receptor antagonist pharmaceuticals |
| 05/23/2002 | US20020061874 Substituted lactam; gamma-secretase inhibitor; decreases production of beta-amyloid; treatment for Altzheimer's and Down's syndrome |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | US20020061840 Tripeptide compounds useful as selective inhibitors of aminopeptidase A and corresponding pharmaceutical compositions |
| 05/23/2002 | CA2428802A1 Camptothecin compounds with a sulfhydryl group |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206484A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/22/2002 | EP1206449A1 Lactam inhibitors of hepatitis c virus ns3 protease |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206273A2 Peptides that block viral infectivity and methods of use thereof |
| 05/22/2002 | EP1206272A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/22/2002 | CN1350548A Long lasting insulinotropic peptides |
| 05/22/2002 | CN1350545A Spray drying of thrombin inhibitors |
| 05/22/2002 | CN1350525A 1,3,4-oxadiazole derivatives and process for producing the same |
| 05/21/2002 | US6392046 Aids therapy |
| 05/21/2002 | US6391919 Aids therapy |
| 05/21/2002 | US6391856 Method for treatment of allergic reaction using formyl peptide |
| 05/21/2002 | US6391855 Compounds and methods for modulating junctional adhesion molecule-mediated functions |
| 05/21/2002 | US6391305 Conjugates useful in the treatment of prostate cancer |
| 05/21/2002 | CA2082636C Process for the preparation of sulfonylpristinamycin iib |
| 05/21/2002 | CA2059909C Alkylation of azaglycine derivatives |
| 05/21/2002 | CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same |
| 05/16/2002 | WO2002038796A2 Methods for determining protease cleavage site motifs |
| 05/16/2002 | WO2002038591A1 Fap-activated anti-tumor compounds |
| 05/16/2002 | WO2002038590A1 Fap-alpha-activated anti-tumor compounds |
| 05/16/2002 | WO2002038540A2 Activity-dependent cysteine protease profiling reagent |
| 05/16/2002 | WO2002038187A1 Fap-activated anti-tumour prodrug |
| 05/16/2002 | WO2002038108A2 Methods of treating disorders related to apoe |
| 05/16/2002 | WO2002038107A2 Stat modulators |
| 05/16/2002 | WO2002007770A3 Polymeric conjugates of antitumor agents |
| 05/16/2002 | WO2001081368A3 Blood-pressure reducing polypeptides containing vpp derived from microorganisms |
| 05/16/2002 | WO2001081366A3 Purification of ace inhibiting polypeptides containing vpp from milk |
| 05/16/2002 | WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors |
| 05/16/2002 | WO2001068678A3 Peptides that selectively bind to expanded polyglutamine repeat domains and methods of use thereof |
| 05/16/2002 | US20020058784 Generation of preferential compound; obtain sample of diamino acid such as 2,3 diaminopropionic acid, incubate with compound with free amino group, recover urein |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058629 S-nitrosothiols as agents for the treatment of circulatory dysfunctions |